Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Botulinum Toxin-What Urologic Uses Does the Data Support?
Potential Beneficial Effects of Marine Peptide on Human Neuron Health.
Novartis MS pill heads stream of SMC approvals
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.
Multiple sclerosis drugs: how much bang for the buck?
Need for the upcoming revision of the current diagnostic criteria for NMO - response to the letter from Zhou et al.
4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review.
Short Peptide Type I Interferon Mimetics; Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections.
Multiple Sclerosis: Current Knowledge and Future Outlook.
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status.
CMT4D (NDRG1 mutation): genotype-phenotype correlations.
Hydration status substantially affects chronic cerebrospinal venous insufficiency assessments.
Emerging role of interleukin-22 in autoimmune diseases.
[The Effect of the Disease Duration on the Changes of the Visual Evoked Potentials and Contrast Sensitivity in Multiple Sclerosis].
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.
Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice.
Primary CNS lymphoma masquerading as tumefactive demyelination.
The development of myelin repair agents for treatment of multiple sclerosis: Progress and challenges.
Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.
TRO19622 Promotes Myelin Repair in a rat Model of Demyelination.
Balkans syndrome: a potential link between multiple sclerosis and hypervaccination.
[Ultrahigh field MRI in context of neurological diseases.]
Pages
« first
‹ previous
…
386
387
388
389
390
391
392
393
394
…
next ›
last »